articleThe Journal of Clinical Endocrinology & MetabolismNov 1, 2002Closed access

Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia

Tokyo Metropolitan Kiyose Children's Hospital · The University of Tokyo · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Hypophosphatemic rickets/osteomalacia with inappropriately low serum 1,25-dihidroxyvitamin D level is commonly observed in X-linked hypophosphatemic rickets/osteomalacia, autosomal dominant hypophosphatemic rickets/osteomalacia and tumor-induced osteomalacia. Although the involvement of a newly identified factor, FGF-23, in the pathogenesis of ADHR and TIO has been suggested, clinical evidence indicating the role of FGF-23 has been lacking. We have previously shown that FGF-23 is cleaved between Arg(179) and Ser(180), and this processing abolished biological activity of FGF-23 to induce hypophosphatemia. Therefore, sandwich ELISA for biologically active intact human FGF-23 was developed using two kinds of…

Citation impact

675
total citations
FWCI
15.39
Percentile
100%
References
0
Citations per year

Authors

11

Topics & keywords

Keywords
  • Osteomalacia
  • Hypophosphatemia
  • Hypophosphatemic Rickets
  • Fibroblast growth factor 23
  • Internal medicine
  • Endocrinology
  • Rickets
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.